TARTRATE SALTS OF QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY
申请人:Cai Xiong
公开号:US20090076022A1
公开(公告)日:2009-03-19
The present invention relates to tartrate salts of quinazoline containing zinc-binding moiety based derivatives that are inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The tartrate salts may further act as HDAC inhibitors.
本发明涉及含有
锌结合基团的
喹唑啉酸盐衍
生物,这些衍
生物是
表皮生长因子受体
酪氨酸激酶(
EGFR-TK)的
抑制剂,以及它们在治疗
EGFR-TK相关疾病和疾病如癌症中的用途。这些
酒石酸盐还可能作为H
DAC抑制剂。